J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data

The positive data update has put the spotlight on a number of ETFs that could benefit from their high exposure to Johnson & Johnson.

Find out more at https://ift.tt/3lVCtA9
via Entrepreneur.com